Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-14
2007-08-14
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S424000, C514S369000, C548S524000, C548S543000, C548S182000, C548S201000, C548S202000
Reexamination Certificate
active
10542724
ABSTRACT:
The pharmaceutical composition comprising the compound of the invention having 8-azaprostaglandin skeleton represented by formula (I)(wherein, all the symbols have the same meanings as that of the specification) a salt thereof, a solvate thereof or a cyclodextrin clathrate thereof, or a prodrug thereof and them as active ingredient have EP4agonistic action and thus are considered useful for the prevention and/or treatment of immunological diseases, asthma, neuronal cell death, arthritis, lung failure, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, liver damage, acute hepatitis, nephritis, renal insufficiency, hypertension, myocardial ischemia, systemic inflammatory response syndrome, sepsis, hemophagous syndrome, macrophage activation syndrome, Still's disease, Kawasaki disease, burn, systemic granulomatosis, ulcerative colitis, Crohn's disease, hypercytokinemia at dialysis, multiple organ failure, shock and glaucoma, etc. Furthermore, the compounds also have an action of accelerating bone formation, so it is expected to be useful for the prevention and/or treatment of diseases associated with loss in bone mass, for example, primary osteoporosis, secondary osteoporosis, bone metastasis of cancer, hypercalcemia, Paget's disease, bone loss, osteonecrosis, bone formation after bone operation, alternative treatment for bone grafting.
REFERENCES:
patent: 4177346 (1979-12-01), Nelson
patent: 6552067 (2003-04-01), Cameron et al.
patent: 2003/0207925 (2003-11-01), Cameron et al.
patent: 2005/0020686 (2005-01-01), Maruyama et al.
patent: 1 110 949 (2001-06-01), None
patent: 1 121 939 (2001-08-01), None
patent: 1 132 086 (2001-09-01), None
patent: 5-321159 (1993-12-01), None
patent: 2001-181210 (2001-07-01), None
patent: 2001-220357 (2001-08-01), None
patent: 2001-233792 (2001-08-01), None
patent: WO 03/009872 (2003-02-01), None
patent: WO 03/047417 (2003-06-01), None
patent: WO 03/047513 (2003-06-01), None
patent: WO 03/077908 (2003-09-01), None
patent: WO 03/077910 (2003-09-01), None
patent: WO 03/097596 (2003-11-01), None
patent: WO 03/103604 (2003-12-01), None
International Search Report dated Mar. 16, 2004.
Abe Nobutaka
Fujimura Shinsei
Kambe Tohru
Kobayashi Kaoru
Maruyama Takayuki
Chu Yong
ONO Pharmaceutical Co., Ltd.
Saeed Kamal A.
LandOfFree
8-azaprostaglandin derivatives and medical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-azaprostaglandin derivatives and medical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-azaprostaglandin derivatives and medical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3873712